Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

NeuroOne Medical Technologies Corporation Registered Shs Aktie 110904763 / US64130M2098

11.12.2025 22:04:42

EQS-News: NeuroOne(R) to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Wednesday, December 17th at 8:30 a.m. Eastern Time

EQS-News: NeuroOne Medical Technologies / Key word(s): Financial
NeuroOne(R) to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Wednesday, December 17th at 8:30 a.m. Eastern Time

11.12.2025 / 22:04 CET/CEST
The issuer is solely responsible for the content of this announcement.


EDEN PRAIRIE, MINN. - December 11, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal fourth quarter and year ended September 30, 2025, before market open on December 17, 2025.

Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Wednesday, December 17, 2025, to discuss the Company’s fourth quarter and full fiscal year 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:

Fiscal Fourth Quarter 2025 Earnings Conference Call
Date: Wednesday, December 17, 2025
Time: 8:30 a.m. Eastern time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 924910
Webcast: NMTC FY Q4 2025 Earnings Call Webcast

Please join at least five minutes before the start of the call to ensure timely participation

A playback of the call will be available through Wednesday, December 31, 2025. To listen to the replay, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 53302. A webcast replay will also be available using the webcast link above through Wednesday, December 31, 2025.

About NeuroOne

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.

IR Contact
MZ Group - MZ North America
NMTC@mzgroup.us

View the original release on www.newmediawire.com


News Source: NeuroOne Medical Technologies


11.12.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: NeuroOne Medical Technologies
United States
ISIN: US64130M2098
EQS News ID: 2244470

 
End of News EQS News Service

2244470  11.12.2025 CET/CEST

Analysen zu NeuroOne Medical Technologies Corporation Registered Shs

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

KI-Hype – Wer profitiert? Wall Street Live mit Tim Schäfer

Welche Unternehmen profitieren vom KI-Hype – auch abseits der bekannten Tech-Giganten wie Nvidia, Microsoft oder Alphabet?

Im heutigen Interview analysiert Tim Schaefer @TimSchaeferMedia die zweite Reihe der KI-Profiteure: Energieversorger, Rechenzentren, Kühlung, Infrastruktur & Software. Denn wo grosse Sprachmodelle und KI-Anwendungen betrieben werden, braucht es vor allem eins: Strom, Speicher und Struktur.

💡 Welche Unternehmen profitieren indirekt vom KI-Boom?
💡 Welche Branchen bieten stabile Dividenden bei solider Bewertung?

Eine spannende Analyse für alle, die KI-Investments breiter denken wollen.

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

KI-Hype – Wer profitiert? Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’480.71 19.00 BTASKU
Short 13’721.45 13.97 S8QBLU
Short 14’290.05 8.61 B94SVU
SMI-Kurs: 12’905.17 11.12.2025 17:31:31
Long 12’384.65 19.29 SO3BSU
Long 12’121.81 13.89 SPMB5U
Long 11’608.20 8.97 SYZBYU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com